Short-term Impact of COVID-19 Lockdown on Metabolic Control of Type 2 Diabetes
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04501991|
Recruitment Status : Completed
First Posted : August 6, 2020
Last Update Posted : August 6, 2020
|Condition or disease||Intervention/treatment|
|Type 2 Diabetes Metabolic Control||Other: antidiabetic treatment|
All the patients with type 2 diabetes who were previously scheduled for a follow-up visit in our outpatient diabetes clinic during the lockdown for COVID-19 (March 9, 2020-May 04, 2020) were contacted by phone. Patients who accepted to take part of the study received a medical prescription for routine analysis via email. They were asked to perform blood drawing one week after the end of the lockdown period and transmitted us the results.
We then compared the metabolic profile tested one week after the end of the lockdown with the last value and the mean of the last three determinations performed before the pandemic emergency.
|Study Type :||Observational|
|Actual Enrollment :||114 participants|
|Official Title:||Determining the Impact of COVID-19 Lockdown on Metabolic Control in Individuals With Type 2 Diabetes|
|Actual Study Start Date :||March 11, 2020|
|Actual Primary Completion Date :||May 4, 2020|
|Actual Study Completion Date :||June 30, 2020|
Patients with Type 2 Diabetes
Patients with type 2 diabetes and a scheduled visit during the lockdown for COVID-19
Other: antidiabetic treatment
Every kind of antidiabetic treatment, oral or injective, were considered including patients treated only with diet
- Glucose [ Time Frame: One week after the end of the lockdown period ]Blood glucose was expressed in mg/dl and was determined by standard techniques.
- HbA1c [ Time Frame: One week after the end of the lockdown period ]HbA1c was expressed as percentage or mmol/l and was determined by standard techniques.
- Lipid profile [ Time Frame: One week after the end of the lockdown period ]Complete lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol, Triglcerydes) were expressed in mg/dl or mmol/l and were determined by standard techniques.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04501991
|University of Pisa|
|Pisa, Italy, 56125|
|Principal Investigator:||Anna Solini, MD, PhD||University of Pisa|